AstraZeneca PLC
AstraZeneca PLC (AZN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AZN · as of Jun 8, 2026
Key Statistics
Explore AstraZeneca PLC Data
azn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 41 · Buy rate: 48.8%
The AZN analyst consensus is Buy, based on ratings from 41 Wall Street analysts over the past 3 months. The average 12-month price target is $216.00, representing +16.16% upside from the current price of $185.95.
Competitors & Peers
azn competitorsAZN
ABBV
AMGN
BMY
GILD
GSKStock Performance
Full HistoryAbout AstraZeneca PLC
AstraZeneca PLC a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imf…
what is astrazeneca plc · azn stock overview · astrazeneca plc company profile · who is astrazeneca plc ceo · azn NYSE · astrazeneca plc headquarters · astrazeneca plc business segments
About Stock Overview & Key Data
AstraZeneca PLC (AZN) is a Healthcare company in the Drug Manufacturers - General industry, listed on NYSE since May 12, 1993. As of the latest trading session, AZN stock price is $185.95, with a market capitalization of $288.4B. The stock has returned +26.91% over the past 12 months and +5.95% year-to-date.
According to 41 Wall Street analysts, the consensus rating for AstraZeneca PLC stock is Buy, with an average 12-month price target of $216.00. In fiscal year 2025, AstraZeneca PLC reported revenue of $58.7B and net income of $10.3B. For detailed data — including AstraZeneca PLC revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, AstraZeneca PLC (AZN) stock price is $185.95. The stock is traded on NYSE under the ticker symbol AZN. The 52-week range is $137.22 – $212.71.